多提努拉德在患有晚期慢性病的患者的疗效和安全性

相关实验视频

Updated: Sep 10, 2025

11:18

Direct Drug Delivery to Kidney via the Renal Artery

Published on: April 17, 2021

7.5K

Teppei Motomura¹, Mayuka Higashi¹, Akihisa Hattori¹

¹Department of Nephrology, Ibaraki Prefectural Central Hospital, Ibaraki Cancer Center, Japan.

Internal medicine (Tokyo, Japan)

|August 20, 2025

概括

在患有晚期慢性病 (CKD) 的患者中,多提努拉德有效降低血清尿酸. 在研究小组中,这种尿素酸药物表现出安全性,而不会影响功能.

科学领域:

腎臟病學 (nephrology) 是一種醫學專業.
药理学药理学是指药理学的学科.
心血管医学心血管医学

背景情况:

高尿路血是心血管疾病和慢性病 (CKD) 的已知危险因素.
有限的数据存在于dotinurad的有效性和安全性,一个尿素酸剂,在患有晚期CKD (G3b-G5阶段) 的患者.
在这个人群中,评估多丁努拉德对血清尿酸和功能的影响至关重要.

研究的目的:

评估多提努拉德在降低晚期CKD的高尿血症患者血清尿酸水平方面的疗效.
评估dotinurad在该患者队列中的安全性.
为了确定多提努拉德对功能的影响,具体估计球透率 (eGFR).

主要方法:

一个单一的中心,回顾性观察性研究.
分析了接受多丁努拉德的14名患有CKD G3b-G5的患者.
血清尿酸和eGFR在治疗开始前六个月和之后被测量.

主要成果:

在六个月的多提努拉德治疗后,血清尿酸水平显著下降,从8.2 mg/dL降至6.2 mg/dL (p<0.01).
在研究期间,估计的膜过率 (eGFR) 没有显著变化.
没有报告任何不良事件,这表明安全性概况有利.

结论:

在晚期CKD (G3b-G5) 患者中,多提努拉德有效降低血清尿酸水平.
这种药物在这个人群中使用似乎是安全的.
根据eGFR测量,多提努拉德没有对功能产生不良影响.

关键词:

慢性脏疾病慢性脏疾病在Dotinurad的位置上.超血症是什么意思

相关概念视频

01:11

Renal Failure: Dose Adjustments

153

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...

153

01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...

01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...

01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...

01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...